| MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer L Zhang, Y Liao, L Tang Journal of Experimental & Clinical Cancer Research 38, 1-13, 2019 | 495 | 2019 |
| Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription L Tang, E Nogales, C Ciferri Progress in biophysics and molecular biology 102 (2-3), 122-128, 2010 | 346 | 2010 |
| The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review J Zhou, Q Yi, L Tang Journal of Experimental & Clinical Cancer Research 38, 1-11, 2019 | 275 | 2019 |
| Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance S Li, Y Song, C Quach, H Guo, GB Jang, H Maazi, S Zhao, NA Sands, ... Nature communications 10 (1), 1693, 2019 | 160 | 2019 |
| Salvianolic acids: potential source of natural drugs for the treatment of fibrosis disease and cancer L Ma, L Tang, Q Yi Frontiers in pharmacology 10, 97, 2019 | 111 | 2019 |
| RBFox2 binds nascent RNA to globally regulate polycomb complex 2 targeting in mammalian genomes C Wei, R Xiao, L Chen, H Cui, Y Zhou, Y Xue, J Hu, B Zhou, T Tsutsui, ... Molecular cell 62 (6), 875-889, 2016 | 105 | 2016 |
| The role of cold‐inducible RNA binding protein in cell stress response Y Liao, L Tong, L Tang, S Wu International journal of cancer 141 (11), 2164-2173, 2017 | 104 | 2017 |
| Fabrication of selenium-deposited and chitosan-coated titania nanotubes with anticancer and antibacterial properties X Chen, K Cai, J Fang, M Lai, Y Hou, J Li, Z Luo, Y Hu, L Tang Colloids and Surfaces B: Biointerfaces 103, 149-157, 2013 | 104 | 2013 |
| SPARC in tumor pathophysiology and as a potential therapeutic target J Feng, L Tang Current Pharmaceutical Design 20 (39), 6182-6190, 2014 | 100 | 2014 |
| The application of lncRNAs in cancer treatment and diagnosis Y Zhang, L Tang Recent patents on anti-cancer drug discovery 13 (3), 292-301, 2018 | 94 | 2018 |
| The MGF expression of osteoblasts in response to mechanical overload LL Tang, CY Xian, YL Wang Archives of Oral Biology 51 (12), 1080-1085, 2006 | 66 | 2006 |
| Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway L He, Y Chen, J Feng, W Sun, S Li, M Ou, L Tang The international journal of biochemistry & cell biology 90, 29-37, 2017 | 60 | 2017 |
| Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities Q Pei, Q Yi, L Tang International journal of molecular sciences 24 (11), 9671, 2023 | 54 | 2023 |
| Function of TREM1 and TREM2 in liver-related diseases H Sun, J Feng, L Tang Cells 9 (12), 2626, 2020 | 54 | 2020 |
| Substrate Stiffness Drives Epithelial to Mesenchymal Transition and Proliferation through the NEAT1-Wnt/β-Catenin Pathway in Liver Cancer X Xu, Y Zhang, X Wang, S Li, L Tang International Journal of Molecular Sciences 22 (21), 12066, 2021 | 50 | 2021 |
| Effect of actin cytoskeleton disruption on electric pulse‐induced apoptosis and electroporation in tumour cells D Xiao, L Tang, C Zeng, J Wang, X Luo, C Yao, C Sun Cell biology international 35 (2), 99-104, 2011 | 48 | 2011 |
| The effect of step-wise increased stretching on rat calvarial osteoblast collagen production LL Tang, YL Wang, J Pan, SX Cai Journal of biomechanics 37 (1), 157-161, 2004 | 46 | 2004 |
| Mechano growth factor E peptide regulates migration and differentiation of bone marrow mesenchymal stem cells H Cui, Q Yi, J Feng, L Yang, L Tang Journal of molecular endocrinology 52 (2), 111-120, 2014 | 45 | 2014 |
| MicroRNA 320, an anti-oncogene target miRNA for cancer therapy Y Liang, S Li, L Tang Biomedicines 9 (6), 591, 2021 | 43 | 2021 |
| Targeting BRD9 for cancer treatment: a new strategy X Zhu, Y Liao, L Tang OncoTargets and therapy, 13191-13200, 2020 | 43 | 2020 |
